VIA Disc NP Registry

NCT04652687 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 83

Last updated 2024-05-10

No results posted yet for this study

Summary

Registry is to observe and trend patterns of care and outcomes for patients treated with VIA Disc NP.

Conditions

Interventions

OTHER

VIA Disc NP (HCT/P)

VIA Disc NP - Allograft tissue injection

Sponsors & Collaborators

  • VIVEX Biologics, Inc.

    lead INDUSTRY

Principal Investigators

  • Lisa Finstein, MHA · Vivex Biologics

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-03
Primary Completion
2024-03-05
Completion
2024-03-05

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04652687 on ClinicalTrials.gov